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Long-term outcomes of 23-gauge transconjunctival
sutureless vitrectomy
Mehmet ÇITIRIK, Coşar BATMAN, Tolga BİÇER, Arsen AKINCI

Aim: To assess the long-term efficacy and safety of 23-gauge transconjunctival sutureless pars plana vitrectomy in the
management of vitreoretinal diseases.
Materials and methods: In this study, 53 eyes of patients who underwent 23-gauge transconjunctival sutureless pars
plana vitrectomy were included. A complete ophthalmological examination was performed preoperatively and at day 1,
week 1, and months 1, 3, 6, and 12 after the surgery.
Results: The mean age of the patients was 56.3 years (range: 22-73). Overall, the mean preoperative best-corrected visual
acuity was 20/800, and the final mean postoperative best-corrected visual acuity at the 12-month visit was 20/160. The
overall rate of eyes having an increased best-corrected visual acuity was 75.4% at month 12. Subconjunctival haemorrhage
was observed in 7 eyes (13.2%), move of trocar in 4 eyes (7.5%), and fluid leakage to conjunctival entry sites in 2 eyes
(3.7%). Postoperative complications included cataract formation in 8 of 31 eyes (25.8%), elevated intraocular pressure
in 8 eyes (15.1%), hypotonia in 4 eyes (7.5%), subconjunctival bleb of silicone oil in 1 of 15 eyes (6.6%), and conjunctival
irritation in 2 eyes (3.7%).
Conclusion: According to the results of this study, vitreoretinal surgery with 23-gauge transconjunctival sutureless
vitrectomy appears to be an effective and safe technique for the management of posterior segment diseases.
Key words: 23-Gauge pars plana vitrectomy, intraoperative complications, postoperative complications, transconjunctival
sutureless vitrectomy

23-Gauge transkonjonktival sütürsüz vitrektominin uzun dönem sonuçları
Amaç: 23-Gauge transkonjonktival sütürsüz pars plana vitrektominin vitreoretinal hastalıklarının yönetiminde uzun
dönem etkinliğini ve güvenilirliğini tespit etmek.
Yöntem ve gereç: 23-Gauge transkonjonktival sütürsüz pars plana vitrektomi uygulanan 53 hastanın 53 gözü bu
çalışmaya alındı. Hastalar ameliyat öncesinde ve ameliyattan sonra birinci gün, birinci ay, üçüncü ay, altıncı ay ve on
ikinci ayda muayene edildi. Olguların başlangıç ve takip muayenelerinde tüm göz muayene bulguları değerlendirildi.
Bulgular: Tüm hastalarda ortalama yaş 56,3 yıl idi (22-73 yıl). Hastalarımızda ameliyat öncesi ortalama görme keskinliği
20/800 düzeyinde idi. Ameliyat sonrası on ikinci ayda bu değer ortalama 20/160 düzeyine yükseldi. On ikinci aydaki
değerlendirmede olguların % 75,4’ünde görme keskinliği düzeyinde artış belirlendi. Subkonjonktival kanama 7 gözde
(% 13,2), trocarın yerinden çıkması 4 gözde (% 7,5) ve konjonktiva giriş yerinde sıvı sızdırması 2 gözde (% 3,7) tespit
edildi. Ameliyat sonrası komplikasyonlar olarak 8 gözde (31 gözün 8’inde) katarakt (% 25,8), 8 gözde göz içi basınç
yüksekliği (% 15,1), 4 gözde hipotoni (% 7,5), 1 gözde (15 gözün 1’inde) silikon yağına bağlı subkonjonktival bleb ve 2
gözde konjonktiva iritasyonu (% 3,7) belirlendi.
Sonuç: Bu çalışmanın sonuçlarına göre 23-gauge transkonjonktival sütürsüz pars plana vitrektomi arka segment
hastalıklarının yönetiminde etkin ve güvenilir bir yöntemdir.
Anahtar sözcükler: 23-Gauge pars plana vitrektomi, intraoperatif komplikasyonlar, postoperatif komplikasyonlar,
transkonjonktival sütürsüz vitrektomi
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Introduction
The 20-gauge pars plana vitrectomy (PPV)
procedure is the most commonly performed operation
in modern vitreoretinal practice. The disadvantages of
20-gauge PPV include excess traumatic conjunctival
and scleral manipulation, less postoperative patient
comfort, more postoperative corneal astigmatism,
extended visual recovery, and greater postoperative
intraocular inflammation (1). Suture related
problems such as suture erosion, scleral necrosis, and
granulation formation may occur in this technique
(2). Development of vitreoretinal surgical techniques
is of interest in efforts to ensure minimal damage or
lesions to tissues. Chen (3) described a new technique
of creating self-sealing pars plana sclerotomies in
1996. In 2002, Fujii et al. (4) developed the feasibility
of a 25-gauge transconjunctival sutureless pars plana
vitrectomy (TSPPV) system. Although this method
had found favour with many vitreoretinal specialists,
a significant proportion has found the thin 25-gauge
instrumentation to be too flexible (5). In response,
Eckardt (6) developed a 23-gauge instrumentation
method for TSPPV in 2005. TSPPV depends on
smaller diameter instruments and conjunctival
displacement before making the transconjunctival
sclerotomies so that the conjunctiva covers the
sclerotomy after surgery is completed.
In this study, we evaluated the long-term
outcomes and complications of 23-gauge TSPPV in
the management of vitreoretinal disease.
Materials and methods
All procedures were conducted in accordance with
the Declaration of Helsinki, and informed consent
was obtained from all patients. This prospective study
was performed with standard 23-gauge TSPPV in 53
eyes of 53 patients who were admitted to the Turkish
Ministry of Health Ankara Ulucanlar Eye Education
and Research Hospital Retina Clinic between July
2006 and September 2007. Patients with a history of
prior vitreoretinal surgery and any corneal pathology
were excluded from the study. Prior to the surgical
intervention, a complete ophthalmologic examination
was performed, including best-corrected visual acuity
(BCVA), intraocular pressure (IOP) with applanation
tonometry, slit-lamp biomicroscopy, and dilated
fundus examination. Visual acuity was measured
1022

with the Snellen chart. For statistical analysis, Snellen
values were converted to the logMAR chart. Followup examinations were performed at day 1, week 1,
and months 1, 3, 6, and 12 after surgery. All patients
diagnosed with nonclearing vitreous haemorrhage
had a preoperative ultrasonography for the detection
of coexisting retinal detachment.
The 23-gauge TSPPV was performed for the
following retinal conditions: proliferative diabetic
retinopathy with vitreous haemorrhage (n = 25),
rhegmatogenous retinal detachment (n = 13), central
retinal vein occlusion with vitreous haemorrhage
(n = 5), idiopathic macular hole (n = 4), idiopathic
epiretinal membrane (n = 3), and vitreous
condensation secondary to Behçet’s disease (n =
3). The preoperative characteristics of patients are
summarised in Table 1.
All surgeries were performed under local
anaesthesia by retrobulbar injection. The Dutch
Ophthalmic Research Company (DORC, Zuidland,
Netherlands) 23-gauge system was used in all cases.
The technique used in every case was the insertion
of a cannula, using a bevelled trocar, following
displacement of the conjunctiva to purposefully
misalign the conjunctival and scleral incisions
with oblique entries. Transscleral cannulae were
placed through the pars plana in the superonasal,
superotemporal, and inferotemporal quadrants,
according to standard vitrectomy protocol. All eyes
underwent core vitrectomy followed by the removal
of the posterior hyaloid membrane and vitreous
traction. Retinal photocoagulation was performed
in the selected eyes. In the required eyes, the fluid
in the vitreous cavity was exchanged with air, gas,
or silicone oil after vitrectomy. The infusion line
was then clamped, the superonasal cannula was
removed, and the conjunctiva was repositioned to
cover the sclerotomy completely. The infusion line
was then unclamped and the sclerotomy site was
inspected for fluid leakage. The superotemporal
cannula was removed in the same fashion, using
the clamp-unclamp technique of infusion followed
by inspection. Finally, the inferotemporal cannula
and infusion line were removed en bloc, followed by
the repositioning and inspection of the conjunctiva.
Inferonasal
subconjunctival
antibiotics
and
corticosteroids were then injected.
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Table 1. Preoperative characteristics of the studied patients.
Patients

Sex

Diagnosis

Number

%

Female

23

43.4

Male

30

56.6

Total

53

100

Proliferative diabetic retinopathy with vitreous haemorrhage

25

47.2

Rhegmatogenous retinal detachment

13

24.5

Central retinal vein occlusion with vitreous haemorrhage

5

9.4

Idiopathic macular hole

4

7.5

Idiopathic epiretinal membrane

3

5.7

Vitreous condensation secondary to Behçet’s disease

2

5.7

Total

53

100

Statistical analysis was performed using a 2-tailed
paired t-test and the statistical significance was set as
P < 0.05. All statistics in this study were analysed with
SPSS for Windows (SPSS Inc., Chicago, IL, USA).
Results
This study prospectively enrolled 53 eyes of 53
patients who underwent 23-gauge TSPPV. Of the 53
patients, 30 (56.6%) were male and 23 (43.4%) were
female. The mean age of the patients was (mean ±
SD) 56.3 ± 8.9 (range: 22-73) years. All of patients
were followed for 12 months.
The mean preoperative BCVA was 20/800 (range,
hand motions: 20/30). The mean overall postoperative
BCVA was 20/1000 (range, hand motions: 20/30) at
day 1, 20/800 (range, hand motions: 20/30) at week
1, 20/500 (range, hand motions: 20/30) at month 1,
20/400 (range, hand motions: 20/25) at month 3,
20/200 (range, hand motions: 20/25) at month 6, and
20/160 (range, hand motions: 20/20) at month 12.
Postoperative visual acuity increased in 14 patients
(26.4%) on day 1, 19 patients (35.8%) at week 1, 26
(49.1%) at month 1, 31 (58.5%) at month 3, 37 (69.8%)
at month 6, and 40 patients (75.4%) at month 12.
The visual acuity recorded at the last follow-up was
better than the first visit in 40 eyes (75.4%), worse

in 7 eyes (13.2%), and the same in 6 eyes (11.3%).
The difference between preoperative BCVA and
postoperative BCVA on day 1 (P = 0.72) and week 1 (P
= 0.11) were not statistically significant. A statistically
significant increase in BCVA was established at
the 1-, 3-, 6-, and 12-month visits compared to the
preoperative BCVA (P = 0.001). Secondary epiretinal
membrane formation (n = 2, 3.8%), optic atrophy (n
= 2, 3.8%), subretinal membrane formation (n = 1,
1.9%), cystoid macular oedema (n = 1, 1.9%), and
phthisis bulbi (n = 1, 1.9%) were the leading causes of
visual loss at the 12-month visit.
The mean overall preoperative IOP was (mean
± SD) 13.1 ± 4.09 mmHg (range: 9-20 mmHg). The
mean overall postoperative IOP was 14.3 ± 7.37
mmHg (range: 5-40 mmHg) on day 1, 14.7 ± 7.12
mmHg (range: 10-43 mmHg) at week 1, 14.4 ± 4.60
mmHg (range: 10-35 mmHg) at month 1, 14.03 ±
3.74 mmHg (range: 11-30 mmHg) at month 3, 13.7
± 4.03 mmHg (range: 10-35 mmHg) at month 6,
and 13.34 ± 4.30 mmHg (range: 12-21 mmHg) at
month 12. Hypotony (IOP < 8 mmHg) was observed
in 4 (7.5%) eyes on postoperative day 1. IOP in
these cases normalised within 7 days with pressure
patching. IOPs higher than 22 mmHg were detected
in 8 (15.1%) eyes on postoperative day 1 and were
treated with antiglaucoma drops (brinzolamide
1023
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1%). A common feature of these 8 patients was that
they all received 1000-cSt silicone oil, and 6 of these
patients transiently required ocular hypertension
treatment, with IOP normalising before silicone
oil removal. At month 1, 1 eye required silicone
oil removal, and IOP values were observed to be
between 12 and 19 mmHg during the follow-up.
Secondary to the natural progression of advanced
proliferative diabetic retinopathy, one additional
patient developed intractable neovascular glaucoma.
Molteno tube implantation was performed in this
patient at month 6 for neovascular glaucoma. The
IOP of 41 patients (77.3%) remained within the
normal limits at all times during the postoperative
period (range: 9-20 mmHg). The difference between
preoperative and postoperative IOPs on day 1 (P =
0.36) and at week 1 (P = 0.17), month 1 (P = 0.21),
month 3 (P = 0.33), month 6 (P = 0.54), and month
12 (P = 0.81) were not statistically significant. The
changes in the mean best-corrected visual acuities
are shown in the Figure.
Before surgery, 39 eyes were phakic, 13 eyes were
pseudophakic, and 1 eye was aphakic. Intraoperative
iatrogenic cataract formation was not observed in
any of the eyes, and 8 eyes (15.1%) were operated

on for cataract simultaneously with the vitrectomy.
During the follow-up period, 12 eyes of the 31 phakic
eyes (38.7%) had progression of cataracts, and 8 of
these patients (25.8%) underwent cataract extraction
and intraocular lens implantation.
In patients undergoing 23-gauge TSPPV, a
complete vitreous fill of fluid, air, gas, or silicone oil
tamponade decision was carried out at the conclusion
of each case. As a result, 16 eyes (30.1%) were infused
with fluid, 15 eyes (28.3%) were infused with silicone
oil, 12 eyes (22.6%) were infused with gas, and 10 eyes
(18.8%) were infused with air. Silicone oil tamponade
was achieved with 1000-cSt silicone oil and gas
tamponade was obtained with perfluoropropane.
Postoperative complications occurred in 2 patients
with rhegmatogenous retinal detachment; these
patients developed proliferative vitreoretinopathy
and retinal redetachment at month 1. The retina was
successfully reattached with subsequent 23-gauge
TSPPV in these cases. The silicone oil was completely
removed from all of the eyes, with no significant
residual oil in the anterior chamber or in the vitreous
cavity seen in indirect ophthalmoscopy at the end of
6 months.

0.14
0.12
0.1
The mean visual
acuities

0.08
0.06
0.04
0.02
0

Preoperative

The mean visual acuities
0.025

Postoperative first day

0.02

Postoperative first week

0.025

Postoperative first month

0.04

Postoperative third month

0.05

Postoperative sixth month
Postoperative twelfth
month

0.1
0.125

Figure. Changes in mean best-corrected visual acuities.
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The most commonly reported intraoperative
complications were subconjunctival haemorrhage (7
eyes, 13.2%), move of trocar during manipulation (4
eyes, 7.5%), and fluid leakage to conjunctival entry
sites (2 eyes, 3.7%). In 1 case (1.9%) with vitreous
haemorrhage and tractional retinal detachment,
sclerotomy of the dominant-hand side was converted
into a 20-gauge procedure for the peeling of advanced
subretinal and fibrovascular proliferative membrane.
Subconjunctival egress of silicon oil (1 of 15 eyes,
6.6%) and subconjunctival leaking of infusion fluid (1
of 16 eyes, 6.2%) while removing the upper temporal
and upper nasal cannula were observed at the end of
the surgery. Due to leaking sclerotomies, 3 eyes (5.6%)
required sutures at the end of the case. Postoperative
complications included cataract formation in 8 of
31 eyes (25.8%), elevated IOPs in 8 eyes (15.1%),
hypotonia in 4 eyes (7.5%), subconjunctival bleb of
silicone oil in 1 of 15 eyes (6.6%), and conjunctival
irritation in 2 eyes (3.7%). A localised bleb of

subconjunctival silicone oil was removed during slitlamp examination with a 23-gauge needle in a patient
without reaccumulation of subconjunctival oil. There
were no cases of postoperative retinal or choroidal
detachment. Through the follow-up visits, none of the
53 eyes developed endophthalmitis. Complications
related with 23-gauge TSPPV seen during operation,
at the end of surgery, and at the postoperative period
are summarised in Table 2.
Discussion
A new technique of creating self-sealing pars
plana sclerotomies was described by Chen (3). Kwok
et al. (2) described the modified sutureless sclerotomy
technique, especially in eyes with small interpalpebral
space. Korobelnik et al. (7) subsequently studied 292
self-sealing sclerotomies, of which 22 (7.5%) required
suturing. Fujii et al. (4) first described the 25-gauge
TSPPV, including straight entry through the sclera

Table 2. Complications related with 23-gauge transconjunctival sutureless pars plana vitrectomy.
Complications

Intraoperative

End of surgery

Postoperative

Number

%

Subconjunctival haemorrhage

7

13.2

Move of trocar during manipulation

4

7.5

Fluid leakage to conjunctival entry sites

2

3.7

Conversion to 20-gauge

1

1.9

Subconjunctival egress of silicon oil (15 eyes)

1

6.6

Subconjunctival leaking of infusion fluid (16 eyes)

1

6.2

Suture necessary for sclerotomy

3

5.6

Cataract formation (31 eyes)

8

25.8

Elevated IOPs

8

15.1

Hypotonia

4

7.5

Subconjunctival bleb of silicone oil (15 eyes)

1

6.6

Conjunctival irritation

2

3.7

Retinal detachment

-

-

Choroidal detachment

-

-

Endophthalmitis

-

-
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perpendicular to the limbus. They established that
the use of 25-gauge TSPPV may effectively reduce
operative time in selected cases (4). Many investigators
observed transient postoperative hypotonia after
25-gauge vitrectomy (5-8). Additionally, many
vitreoretinal specialists found that the 25-gauge
instrumentation was too flexible and thin (5). Eckardt
(6) developed 23-gauge instruments that were more
rigid than those of the 25-gauge system, allowing
better peripheral vitrectomy and higher complexity
manoeuvres. The wider lumens of the 23-gauge
instruments also improved illumination and fluid
flow and reduced the net vitrectomy time (6).
However, using the larger gauge system theoretically
introduces additional concerns related with wound
leakage, including hypotony, choroidal detachment,
the leakage of tamponade agents resulting in a
subsequent shorter tamponade effect, filtering bleb
formation at sclerotomy sites, subconjunctival
tamponade agents, and endophthalmitis. Eckardt
(6) also described the oblique tunnel incision of the
23-gauge TSPPV system using a 2-step approach,
which reduces the potential complication of
postoperative wound leakage. Recently, standard
straight 25-gauge incisions were changed to oblique
incisions to decrease postoperative leakage and to
improve wound closure (9,10).
Lott et al. (11) reported that postoperative visual
acuity improved in 68% of the patients, worsened in
16%, and remained unchanged in 16% with 23-gauge
TSPPV. In our study, visual acuity increased in 75.4%
of the eyes. Visual acuities on the first and last visits
were statistically compared and significant changes
were found (P < 0.05). No significant change in
the BCVA on day 1 and at week 1 was observed. A
statistically significant increase in the BCVA was
noted at the 1-, 3-, 6-, and 12-month visits when
compared to the preoperative visual acuity.
Elevated IOP is a frequent complication in pars
plana vitrectomy (PPV) (12). Higher IOPs were
detected in 28.5% of eyes after 25-gauge TSPPV
and silicone oil injection (13). Shah et al. (14)
reported that 11.1% of patients developed ocular
hypertension after 25-gauge TSPPV with silicone
oil. Of these, all but 1 (5.5%) could not be controlled
with antiglaucoma drops and required silicone oil
removal. An additional patient (5.5%) developed
1026

recalcitrant ocular hypertension due to neovascular
glaucoma. Higher IOPs were detected in 15.1% of
our cases. Elevated IOP was controlled with topical
medication in 6 of 8 eyes (75%). Silicone oil removal
at month 1 was required in 1 eye. An additional
patient developed intractable neovascular glaucoma
secondary to the proliferative diabetic retinopathy.
Hypotony is a serious complication and among
the most important causes of visual loss in 23-gauge
TSPPV. The postoperative hypotony rate was reported
to be between 2.5% and 6.5% of cases after 23-gauge
TSPPV (15,16). We considered hypotony to be
present when the IOP was less than 8 mmHg, as did
Ibarra et al. (5). In the present study, hypotony was
detected in 4 eyes (7.5%) on postoperative day 1, but
it was resolved within 7 days with pressure patching
postoperatively. Lakhanpal et al. (17) reported that
2 of 140 cases (1.4%) exhibited shallow choroidal
detachments after 25-gauge TSPPV, which were
resolved in 1 week. We did not observe choroidal
effusions after 23-gauge TSPPV.
One of the main complications that appeared in
the postoperative period was cataract formation. It
was observed in 79.3% of cases after 25-gauge TSPPV
(5) and 42% of cases after 23-gauge TSPPV (18).
This complication was the result of contact by the
instruments with the posterior capsule in an attempt
to access the vitreous more anteriorly or by contact
between the infusion pathway and the crystalline
during transscleral indentation (1). In the present
study, iatrogenic intraoperative cataract formation
was not observed in any case during surgery. Cataract
progression was noted postoperatively in 38.7% of
the phakic eyes, and 25.8% of these eyes underwent
cataract extraction and intraocular lens implantation.
A previously reported series of 25-gauge
vitrectomies demonstrated wound leakage requiring
suture placement in 7% of the cases (17). Lott et al.
(11) reported that no sutures were required to close
sclerotomies in 100 patients undergoing 23-gauge
TSPPV. In our series, 3 eyes (5.6%) required sutures
at the end of the case for leaking sclerotomies. We had
to convert to the 20-gauge technique in 1 case (1.9%),
for peeling of advanced subretinal and fibrovascular
membrane.
The 23-gauge TSPPV obviates the need for
conjunctival peritomy and suturing, and also has
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the advantages of the minimally invasive, sutureless
vitrectomy system. Severe chemosis was noted in a
study by Lott et al. (11) after 23-gauge TSPPV. In the
present study, 2 patients (3.7%) complained about
subjective conjunctival irritation on postoperative
day 1. The postoperative silicone oil bleb formation
rate was reported as 5.7% after 25-gauge TSPPV (19).
In the present study, subconjunctival bleb of silicone
oil was observed in 1 of 15 eyes (6.6%).
The reported incidence of endophthalmitis was
0.018% after 20-gauge vitrectomy and 0.23% after
25-gauge TSPPV (20). No cases of endophthalmitis
were observed in our study, despite the theoretically
increased risk of infection created by unsutured
sclerotomies. This result may be attributable to the
superior wound construction, with a longer scleral
tunnel, that is generated with the 23-gauge system.
Furthermore, an oblique incision (not straight) with
23-gauge TSPPV is less likely to provide a tract for
the bacteria to enter the eye.
Tewari et al. (18) reported that retinal tearing
during 23-gauge transconjunctival sutureless
vitrectomy (TSV) occurred in only 1 of 81 eyes
(1.2%). Park et al. (21) reported that retinal tearing
during posterior manipulations occurred in 8.6% of

eyes from the 23-gauge group and 15.2% of eyes from
the 20-gauge group. In the present study, retinal tears
were not observed.
Azar-Arevalo et al. (22) reported that 20-gauge
PPV surgery induced central curvature changes,
as well as asymmetrical peripheral changes. Their
analysis shows that the corneal optical quality
and the asymmetricity of the anterior chamber
curvature deteriorate after 20-gauge PPV. Citirik et
al. (23) compared the changes in corneal curvature
after 25-gauge TSPPV and conventional PPV. They
reported that 25-gauge TSPPV does not significantly
alter the corneal curvature, while the conventional
pars plana incision changes the shape of central
cornea. Less surgically induced astigmatism and
early stabilisation in the 23-gauge TSPPV compared
to the 20-gauge PPV were reported (24).
According to the results of this study, vitreoretinal
surgery with 23-gauge transconjunctival sutureless
vitrectomy appears to be an effective and safe
technique for the management of posterior segment
diseases. Postoperative cataract formation was the
most common complication observed. Postoperative
endophthalmitis was not noted in this long-term case
series.
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